Novavax Inc is a biotechnology business with stocks listed in the US. Novavax shares (NVAX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$5.57 – an increase of 2.01% over the previous week. Here's how to invest if you're based in Australia.
Our top pick for
US stocks
Our top pick for
Low costs
Our top pick for
Dividend investing
Novavax's shares were split on a 1:20 basis on 10 May 2019. So if you had owned 20 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Novavax shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Novavax shares which in turn could have impacted Novavax's share price.
| 52-week range | US$5.3 - US$18.55 |
|---|---|
| 50-day moving average | US$6.7004 |
| 200-day moving average | US$7.5833 |
| Target price | US$19.6 |
| PE ratio | N/A |
| Dividend yield | US$0 (0.93%) |
| Earnings per share (TTM) | US$-6.23 |
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $5.57
| 1 week (2023-11-27) | 2.01% |
|---|---|
| 1 month (2023-11-03) | -21.10% |
| 3 months (2023-09-01) | -32.16% |
| 6 months (2023-06-02) | -26.90% |
| 1 year (2022-12-02) | -66.28% |
|---|---|
| 2 years (2021-12-03) | -96.53% |
| 3 years (2020-12-04) | -95.59% |
| 5 years (2018-12-04) | -86.28% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Over the last 12 months, Novavax's shares have ranged in value from as little as US$5.3 up to US$18.55. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novavax's is 1.725. This would suggest that Novavax's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
| Revenue TTM | US$1 billion |
|---|---|
| Gross profit TTM | US$-156,045,000 |
| Return on assets TTM | -19.51% |
| Return on equity TTM | -898.2% |
| Profit margin | -52.29% |
| Book value | -5.713 |
| Market capitalisation | US$648.6 million |
TTM: trailing 12 months
We're not expecting Novavax to pay a dividend over the next 12 months.
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Steps to owning and managing Microsoft shares from in Australia.
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Learn about the money market and everyday consumer money market products.
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
Follow these tips to find the best share trading platform for you.
